Antibody regulation double-antigen specific T cell, method for preparing same and application of antibody regulation double-antigen specific T cell

A specific, dual-antigen technology, applied in anti-receptor/cell surface antigen/cell surface determinant immunoglobulin, receptor/cell surface antigen/cell surface determinant, botanical equipment and methods, etc. Inability to identify and kill TNBC, poor efficacy of triple-negative breast cancer, manslaughter of normal cells, etc., to ensure specific identification and killing, avoid manslaughter injury, and avoid accidental injury.

Active Publication Date: 2017-05-10
SHENZHEN MORECELL BIOMEDICAL TECH DEV CO LTD
View PDF3 Cites 24 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The purpose of the embodiments of the present invention is to overcome the above-mentioned deficiencies of the prior art, and provide a double-antigen-specific T cell and its preparation method to solve the current technology that cannot effectively identify and kill TNBC, and is likely to cause accidental killing of n

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Antibody regulation double-antigen specific T cell, method for preparing same and application of antibody regulation double-antigen specific T cell
  • Antibody regulation double-antigen specific T cell, method for preparing same and application of antibody regulation double-antigen specific T cell
  • Antibody regulation double-antigen specific T cell, method for preparing same and application of antibody regulation double-antigen specific T cell

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0030] On the other hand, on the basis of the double-antigen-specific T cells of the embodiment of the present invention described above, the embodiment of the present invention also provides a preparation method of the double-antigen-specific T cells of the embodiment of the present invention. The preparation method of the embodiment of the present invention comprises the following steps:

[0031] T cells were simultaneously infected with the first lentivirus and the second lentivirus.

[0032] Wherein, the first lentivirus contains the above-mentioned mesothelin antigen-specific T cell receptor gene. In one embodiment, the first lentivirus is prepared according to the following method:

[0033] S11: Mix the Meso / scFv-CD8-CD3ζ gene fragment with the entry vector, so that the Meso / scFv-CD8-CD3ζ gene fragment is embedded in the entry vector to obtain the Meso / scFv-CD8-CD3ζ gene fragment Entry carrier;

[0034] S12: mixing and recombining the entry vector carrying the Meso / sc...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a double-antigen specific T cell, a method for preparing the same and application of the double-antigen specific T cell. The double-antigen specific T cell comprises mesothelin antigen specific T cell receptor genes and antibody Fc (fibrillar center) fragment specific T cell receptor genes. The antibody Fc fragment specific T cell receptor genes can be mediated by HIF-1 alpha (hypoxia inducible factor-1 alpha) antibodies to specifically recognize HIF-1 alpha antigens. The method includes simultaneously infecting T cells by slow viruses with mesothelin antigen specific T cell receptor genes and slow viruses with antibody Fc fragment specific T cell receptor genes. The double-antigen specific T cell, the method and the application in an embodiment of the invention have the advantages that the double-antigen specific T cell has two specific binding domains and double-specificity for targeting to Meso (mesothelin) and being mediated by the HIF-1 alpha antibodies to specifically recognize the HIF-1 alpha antigens, accordingly, TNBC (triple negative breast cancer) cells can be assuredly specifically recognized and killed by the double-antigen specific T cell, and normal cells of organisms can be prevented from being mistakenly killed.

Description

technical field [0001] The invention belongs to the technical field of biopharmaceuticals, and in particular relates to a double-antigen-specific T cell and a production method thereof, and a pharmaceutical preparation containing double-antigen-specific T cells targeting triple-negative breast cancer cells. Background technique [0002] T lymphocytes are the main effector cells involved in tumor cell immunotherapy, and the activation of T cells is carefully regulated by "dual signals". The first signal is the combination of a specific receptor TCR (T cell receptor) molecule on the surface of T lymphocytes and the antigen peptide presented by the major histocompatibility complex (MHC) on the surface of tumor cells, that is, the T cell’s response to the antigen. Recognition; the second signal is a signal mediated by the interaction of co-stimulatory molecules with corresponding receptors or ligands on the surface of T cells. CD28 / B7 is an important positive co-stimulatory mol...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N5/10C12N15/867A61K39/395A61K47/46A61P35/00
CPCA61K47/46A61K2039/505C07K14/7051C07K14/70517C07K14/70521C07K14/70535C07K16/28C07K16/3015C07K2317/622C07K2319/00C12N5/0636C12N15/86C12N2740/15043
Inventor 不公告发明人
Owner SHENZHEN MORECELL BIOMEDICAL TECH DEV CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products